RankAlpha logo
Back to Rankings

NUWE

NuwellisC
Nasdaq / Health Care Equipment & Services
Last Price
$4.48-$0.42 (-8.57%)
At close · 2026-11-16
View Chart
Current thesis
Pediatric sales growth, 32 consoles sold year to date versus 17 a year earlier, and higher gross margin could improve recurring circuit revenue and operating leverage; FDA clearance would add a distinct adoption opportunity. [#SEC-8K-2026-11-12]
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Operating cash use was $9.3 million for the first nine months of 2026 versus $7.8 million a year earlier, notwithstanding Q3 operating-loss improvement. [#10-Q-2026-11-12]
Momentum
57
Value
56
Sentiment
38
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.50 · Bull $8.00 · Bear $1.50Analysis 2026-11-13; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-11-13 • Vendor: Data Vendor v1
Scores
As of 2026-11-16 • Model: HYBRID_IC_RP
AI Memo
As of 2026-11-13 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-11-16

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-11-16. Definitions

Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Why
Momentum57 · Δ7d -
Value56 · Δ7d 0.0
Sentiment38 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Confirming evidence

  • • Value remains the lead driver in the composite, 7D delta 0.0.

Contradictions & invalidation

  • • Operating cash use was $9.3 million for the first nine months of 2026 versus $7.8 million a year earlier, notwithstanding Q3 operating-loss improvement. [#10-Q-2026-11-12]
  • • Q3 console placements declined year over year; a larger installed base does not yet establish sustained circuit utilization or recurring-revenue growth. [#SEC-8K-2026-11-12]
  • • Flat Q3 sales, fewer Q3 console placements, persistent cash burn and the 10-Q's going-concern warning outweigh the improved quarterly margin until recurring revenue and financing durability are demonstrated.

Catalyst clock

2026-12-31

Q3 results test the operating-improvement thesis

Lead driver: Value · See fundamentals
Momentum
57
18% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
56
43% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
38
39% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade C. Momentum 57.1 / Value 56.4 / Sentiment 38.5

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-11-13. Scenario method

B+
Bull case
20%
Probability
Target price
$8.00
Analysis reference price unavailable
Analysis 2026-11-13 · RankAlpha Sentiment Codex
Most likely
B
Base case
40%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-11-13 · RankAlpha Sentiment Codex
B-
Bear case
40%
Probability
Target price
$1.50
Analysis reference price unavailable
Analysis 2026-11-13 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-11-13
Market Cap
$2.65M
Beta
-0.14
Shares Out
540.92K
P/E (TTM) · Derived
-0.0
P/S (TTM)
0.40
P/FCF (TTM) · Derived
-0.02
Rev YoY
+14.1%
EPS YoY
-98.8%
Gross Margin
+69.7%
Op Margin
-142.9%
Net Debt
-$757K
Current Ratio
1.97
As of 2026-11-16 • Updated nightlySource: Internal modelMethods & Data